Resultats de la cerca - Masamichi Takami
- Mostrar 1 - 18 resultats de 18
-
1
Osteoimmunology: Interactions of the Immune and Skeletal Systems per Jaerang Rho, Masamichi Takami, Yongwon Choi
Publicat 2004Artigo -
2
-
3
-
4
p38 Mitogen-Activated Protein Kinase Is Crucially Involved in Osteoclast Differentiation But Not in Cytokine Production, Phagocytosis, or Dendritic Cell Differentiation of Bone Mar... per Xiaotong Li, Nobuyuki Udagawa, Masamichi Takami, Nobuaki Sato, Yasuhiro Kobayashi, Naoyuki Takahashi
Publicat 2003Artigo -
5
Disabling of Receptor Activator of Nuclear Factor-κB (RANK) Receptor Complex by Novel Osteoprotegerin-like Peptidomimetics Restores Bone Loss in Vivo per Xin Cheng, Masa Kinosaki, Masamichi Takami, Yongwon Choi, Hongtao Zhang, Ramachandran Murali
Publicat 2004Artigo -
6
Suppression of Osteoprotegerin Expression by Prostaglandin E2 Is Crucially Involved in Lipopolysaccharide-Induced Osteoclast Formation per Koji Suda, Nobuyuki Udagawa, Nobuaki Sato, Masamichi Takami, Kanami Itoh, Je‐Tae Woo, Naoyuki Takahashi, Kazuo Nagai
Publicat 2004Artigo -
7
Lipopolysaccharide Promotes the Survival of Osteoclasts Via Toll-Like Receptor 4, but Cytokine Production of Osteoclasts in Response to Lipopolysaccharide Is Different from That of... per Kanami Itoh, Nobuyuki Udagawa, Kanichiro Kobayashi, Koji Suda, Xiaotong Li, Masamichi Takami, Nobuo Okahashi, Tatsuji Nishihara, Naoyuki Takahashi
Publicat 2003Artigo -
8
Interleukin-1β induces death in chondrocyte-like ATDC5 cells through mitochondrial dysfunction and energy depletion in a reactive nitrogen and oxygen species-dependent manner per Rika Yasuhara, Yoichi Miyamoto, Takaaki Akaike, Teruo Akuta, Masanori Nakamura, Masamichi Takami, Naoko Morimura, Kayoko Yasu, Ryutaro Kamijo
Publicat 2005Artigo -
9
Intracellular Calcium and Protein Kinase C Mediate Expression of Receptor Activator of Nuclear Factor-κB Ligand and Osteoprotegerin in Osteoblasts per Masamichi Takami, Naoyuki Takahashi, Nobuyuki Udagawa, Chisato Miyaura, Koji Suda, Je‐Tae Woo, T. John Martin, Kazuo Nagai, Tatsuo Suda
Publicat 2000Artigo -
10
The identification of an osteoclastogenesis inhibitor through the inhibition of glyoxalase I per Makoto Kawatani, Hideo Okumura, Kaori Honda, Naoki Kanoh, Makoto Muroi, Naoshi Dohmae, Masamichi Takami, Mitsuhiro Kitagawa, Yushi Futamura, Masaya Imoto, Hiroyuki Osada
Publicat 2008Artigo -
11
Interferon regulatory factor-8 regulates bone metabolism by suppressing osteoclastogenesis per Baohong Zhao, Masamichi Takami, Atsushi Yamada, Xiaogu Wang, Takako Koga, Xiaoyu Hu, Tomohiko Tamura, Keiko Ozato, Yongwon Choi, Lionel B. Ivashkiv, Hiroshi Takayanagi, Ryutaro Kamijo
Publicat 2009Artigo -
12
Shared and Distinct Functions of the Transcription Factors IRF4 and IRF8 in Myeloid Cell Development per Michio Yamamoto, Takayuki Kato, Chie Hotta, Akira Nishiyama, Daisuke Kurotaki, Masahiro Yoshinari, Masamichi Takami, Motohide Ichino, Masatoshi Nakazawa, T. Matsuyama, Ryutaro Kamijo, Seiichi Kitagawa, Keiko Ozato, Tomohiko Tamura
Publicat 2011Artigo -
13
Reveromycin A, an agent for osteoporosis, inhibits bone resorption by inducing apoptosis specifically in osteoclasts per Je-Tae Woo, Makoto Kawatani, Masanori Kato, Toshimasa Shinki, Takayuki Yonezawa, Naoki Kanoh, Hiroshi Nakagawa, Masamichi Takami, Kun Hyung Lee, Paula H. Stern, Kazuo Nagai, Hiroyuki Osada
Publicat 2006Artigo -
14
Bone loss caused by dopaminergic degeneration and levodopa treatment in Parkinson’s disease model mice per Kazuaki Handa, Shuichi Kiyohara, Tomoyuki Yamakawa, Koji Ishikawa, Masahiro Hosonuma, Nobuhiro Sakai, Akiko Karakawa, Masahiro Chatani, Mayumi Tsuji, Katsunori Inagaki, Yuji Kiuchi, Masamichi Takami, Takako Negishi‐Koga
Publicat 2019Artigo -
15
Interleukin‐4 inhibition of osteoclast differentiation is stronger than that of interleukin‐13 and they are equivalent for induction of osteoprotegerin production from osteoblasts... per Atsushi Yamada, Masamichi Takami, Tadaharu Kawawa, Rika Yasuhara, Baohong Zhao, Ayako Mochizuki, Yoichi Miyamoto, Tomoo Eto, Hisataka Yasuda, Yuko Nakamichi, Nacksung Kim, Takenobu Katagiri, Tatsuo Suda, Ryutaro Kamijo
Publicat 2007Artigo -
16
Tumor Necrosis Factor α Stimulates Osteoclast Differentiation by a Mechanism Independent of the Odf/Rankl–Rank Interaction per Kanichiro Kobayashi, Naoyuki Takahashi, Eijiro Jimi, Nobuyuki Udagawa, Masamichi Takami, Shigeru Kotake, N. Nakagawa, Masahiko Kinosaki, Kyoji Yamaguchi, Nobuyuki Shima, Hisataka Yasuda, Tomonori Morinaga, Kanji Higashio, T. John Martin, Tatsuo Suda
Publicat 2000Artigo -
17
Osteoclast differentiation independent of the TRANCE–RANK–TRAF6 axis per Nacksung Kim, Yuho Kadono, Masamichi Takami, Junwon Lee, Seoung-Hoon Lee, Fumihiko Okada, Jung Ha Kim, Takashi Kobayashi, Paul R. Odgren, Hiroyasu Nakano, Wen‐Chen Yeh, Sun‐Kyeong Lee, Joseph Lorenzo, Yongwon Choi
Publicat 2005Artigo -
18
Porphyromonas gingivalis-derived Lysine Gingipain Enhances Osteoclast Differentiation Induced by Tumor Necrosis Factor-α and Interleukin-1β but Suppresses That by Interleukin-17A per Tomohito Akiyama, Yoichi Miyamoto, Kentaro Yoshimura, Atsushi Yamada, Masamichi Takami, Tetsuo Suzawa, M Hoshino, Takahisa Imamura, C. Akiyama, Rika Yasuhara, Kenji Mishima, Toshifumi Maruyama, Chikara Kohda, Kazuo Tanaka, Jan Potempa, Hisataka Yasuda, Kazuyoshi Baba, Ryutaro Kamijo
Publicat 2014Artigo
Eines de cerca:
Matèries relacionades
Biology
Biochemistry
Cell biology
Chemistry
Receptor
Osteoclast
Activator (genetics)
RANKL
Internal medicine
Medicine
In vitro
Endocrinology
Immunology
Cytokine
Bone resorption
Cancer research
Gene
RANK Ligand
Cellular differentiation
Osteoprotegerin
Molecular biology
Osteoblast
Osteoimmunology
Stem cell
Tumor necrosis factor alpha
Bone marrow
Bone remodeling
Haematopoiesis
Stromal cell
Apoptosis